NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/08/2024
Voltar para busca
Dado oficial do USPTO
IPAM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
44
Atualização mais recente
06/08/2024
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
12/04/2022
Data de registro
06/08/2024
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
06/08/2024
Última transação
06/08/2024
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
SUWON-SI, GYEONGGI-DO, KR
Examinador
GULIANO, ROBERT
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
IMNEWRUN, INC.
imnewrun Biosciences, Inc.
Representantes
DENNIS S. PRAHL LADAS & PARRY LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceuticals for the treatment of cancerepigenetic diseaseneurodegenerative diseasegenetic disorderneuromuscular diseasealzheimer's diseaseparkinson's diseasehuntington's diseaseamyotrophic lateral sclerosismuscle disorderimmune related disorder; Reagents for use in medical genetic testing; Preparations for detecting mutation in prion genes for medical purposes; Diagnostic preparations for medical purposes for detecting presence of mutation in prion genes; medicines for human purposes for the treatment of cancerepigenetic diseaseneurodegenerative diseasegenetic disorderneuromuscular diseasealzheimer's diseaseparkinson's diseasehuntington's diseaseamyotrophic lateral sclerosismuscle disorderimmune related disorder; Pharmaceutical preparations for health care; Vaccines; Diagnostic reagents for medical use; Cultures of Microorganisms for medical purposes; Biotechnological preparations in the nature of enzymes for medical purposes; Stem cells for medical purposes; Enzymes for medical purposes; Nucleic acid sequences for medical and veterinary purposes
Classe 42
Scientific research in the fields of biomedicine; Pharmaceutical drug development services; Research and development of technology for medicinal chemical manufacturing; scientific research in the nature of evaluating clinical trials
Classe 44
Medical and health assessment services relating to DNAgenetics and genetic testing; Genetic testing for medical treatment purposes; Provision of genetic testing for medical treatment purposes; Provision of Genetic information for medical treatment purposes; Providing gene therapy for medical treatment purposes; Genetic counseling for medical purposes; Medical diagnostic testingmonitoring and reporting services; DNA analysis for medical purposes; DNA screening for medical purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
44 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
06/08/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/05/2024
PUBO
PUBLISHED FOR OPPOSITION
21/05/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/05/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
11/04/2024
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
04/04/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/04/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
18/03/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/03/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
18/03/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/03/2024
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
18/03/2024
OTHE
CASE RETURNED TO EXAMINATION
04/03/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
04/03/2024
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
06/02/2024
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
05/02/2024
APET
ASSIGNED TO PETITION STAFF
05/02/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
31/01/2024
EX1G
SOU EXTENSION 1 GRANTED
30/01/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
30/01/2024
EXT1
SOU EXTENSION 1 FILED
12/01/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2024
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
08/01/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18/07/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
23/05/2023
PUBO
PUBLISHED FOR OPPOSITION
23/05/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/05/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
20/04/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/04/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/04/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/04/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
13/01/2023
GNRT
NON-FINAL ACTION E-MAILED
13/01/2023
CNRT
NON-FINAL ACTION WRITTEN
13/01/2023
DOCK
ASSIGNED TO EXAMINER
13/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
29/06/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
10/05/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
09/05/2022
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/05/2022
ALIE
ASSIGNED TO LIE
05/05/2022
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
29/04/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
18/04/2022
NWAP
NEW APPLICATION ENTERED
15/04/2022
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace IPAM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.